Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Open Two-stage Study of Pharmacokinetics, Safety and Efficacy of GP30341, 200 mg Capsules (GEROPHARM LLC, Russia) in Healthy Volunteers and Outpatients With Novel Coronavirus Infection 2019 With a High Risk of Adverse Outcome

NCT05648799 is registered in ClinicalTrials.gov with Geropharm as lead sponsor.

NCT NCT05648799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05648799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Open Two-stage Study of Pharmacokinetics, Safety and Efficacy of GP30341, 200 mg Capsules (GEROPHARM LLC, Russia) in Healthy Volunteers and Outpatients With Novel Coronavirus Infection 2019 With a High Risk of Adverse Outcome
Lead sponsor
Geropharm
Phase
Not applicable
Overall status
Completed
Start date
March 17, 2022
Completion date
July 20, 2022
Enrollment
246 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

efficacy, pharmacokinetics, safety issues